BioTech, Free Full-Text

Por um escritor misterioso
Last updated 17 março 2025
BioTech, Free Full-Text
(1) Background: The COVID-19 pandemic left many intriguing mysteries. Retrospective vulnerability trends tie as strongly to odd demographics as to exposure profiles, genetics, health, or prior medical history. This article documents the importance of nasal microbiome profiles in distinguishing infection rate trends among differentially affected subgroups. (2) Hypothesis: From a detailed literature survey, microbiome profiling experiments, bioinformatics, and molecular simulations, we propose that specific commensal bacterial species in the Pseudomonadales genus confer protection against SARS-CoV-2 infections by expressing proteases that may interfere with the proteolytic priming of the Spike protein. (3) Evidence: Various reports have found elevated Moraxella fractions in the nasal microbiomes of subpopulations with higher resistance to COVID-19 (e.g., adolescents, COVID-19-resistant children, people with strong dietary diversity, and omnivorous canines) and less abundant ones in vulnerable subsets (the elderly, people with narrower diets, carnivorous cats and foxes), along with bioinformatic evidence that Moraxella bacteria express proteases with notable homology to human TMPRSS2. Simulations suggest that these proteases may proteolyze the SARS-CoV-2 spike protein in a manner that interferes with TMPRSS2 priming.
BioTech, Free Full-Text
Biotech typography banner template flat Royalty Free Vector
BioTech, Free Full-Text
Functional protein-based nanomaterial produced in microorganisms
BioTech, Free Full-Text
Journal covers
BioTech, Free Full-Text
Full text link
BioTech, Free Full-Text
Selective isolation and oligotrophic growth of Candida on nutrient
BioTech, Free Full-Text
BioTech December 2021 - Browse Articles
BioTech, Free Full-Text
AI in Biotech: Fashioning the Future of R&D and IP
BioTech, Free Full-Text
PDF) Plant biotechnology in the 21st century: the challenges ahead
BioTech, Free Full-Text
Biotechnology Archives - Onyva Agency
BioTech, Free Full-Text
A new method to customize protein expression vectors for fast
BioTech, Free Full-Text
Biopharma Daily Stock Updates - 04/29/22
BioTech, Free Full-Text
Complete Genomics Launches Full Sequencing Platforms at Biotech

© 2014-2025 startwindsor.com. All rights reserved.